Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05543382 · ClinicalTrials.gov registry record
Cycling Study With the Axonics System
A clinical trial, sponsored by Axonics.
- Terminated
- Registry status
- 31
- Enrollment target
NCT05543382: Clinical Trial study, sponsored by Axonics.
NCT05543382 is a clinical trial that was terminated before completion, run by Axonics. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05543382 was terminated before completion, sponsored by Axonics.
- TERMINATED
- Registry status
- 31 participants
- Enrollment target
Study Summary
A prospective, multi-center, study comparing continuous sacral neuromodulation (SNM) stimulation to daily cyclic stimulation of 2 hours "on" and 22 hours "off" using the Axonics System.
Primary Outcome
Comparison of UUI episodes on a 3-day bladder diary at 3 months as compared to baseline UUI episodes
Interventions
- DEVICE Axonics System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-08-09 |
| Est. Completion | 2024-12-29 |
Why NCT05543382 stopped before completion
NCT05543382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 31 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Axonics System is the first listed.
NCT05543382 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05543382 about?
NCT05543382 is a clinical study titled "Cycling Study With the Axonics System". A prospective, multi-center, study comparing continuous sacral neuromodulation (SNM) stimulation to daily cyclic stimulation of 2 hours "on" and 22 hours "off" using the Axonics System.
What is the current status of trial NCT05543382?
This trial is currently terminated. The enrollment target is 31 participants. The study started on 2022-08-09. Estimated completion is 2024-12-29.
What interventions are being tested in trial NCT05543382?
The interventions under investigation include: Axonics System (DEVICE).
Who is sponsoring clinical trial NCT05543382?
This trial is sponsored by Axonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI